- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x ZID: ISONICOTINIC-ACETYL-NICOTINAMIDE-ADENINE DINUCLEOTIDE(Covalent)
ZID.2: 27 residues within 4Å:- Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199, W.222
- Ligands: NAD.1
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:F.149, A:F.149, A:F.149, A:Y.158
- Hydrogen bonds: A:G.14, A:S.20, A:I.21, A:D.64, A:V.65, A:G.96, A:K.165, A:I.194
- Water bridges: A:A.22, A:F.41, A:F.41, A:F.41, A:D.64, A:I.95, A:T.196, A:T.196
- pi-Stacking: A:F.41
ZID.12: 27 residues within 4Å:- Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199, W.222
- Ligands: NAD.11
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:F.149, B:F.149, B:F.149, B:Y.158
- Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:V.65, B:G.96, B:K.165, B:I.194
- Water bridges: B:A.22, B:F.41, B:F.41, B:F.41, B:D.64, B:I.95, B:T.196, B:T.196
- pi-Stacking: B:F.41
ZID.22: 27 residues within 4Å:- Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199, W.222
- Ligands: NAD.21
22 PLIP interactions:22 interactions with chain C- Hydrophobic interactions: C:F.149, C:F.149, C:F.149, C:Y.158
- Hydrogen bonds: C:G.14, C:S.20, C:I.21, C:V.65, C:G.96, C:K.165, C:I.194
- Water bridges: C:A.22, C:F.41, C:F.41, C:F.41, C:D.64, C:I.95, C:Y.158, C:T.196, C:T.196, C:L.197
- pi-Stacking: C:F.41
ZID.32: 27 residues within 4Å:- Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, Y.158, M.161, K.165, A.191, G.192, P.193, I.194, T.196, M.199, W.222
- Ligands: NAD.31
22 PLIP interactions:22 interactions with chain D- Hydrophobic interactions: D:F.149, D:F.149, D:F.149, D:Y.158
- Hydrogen bonds: D:G.14, D:S.20, D:I.21, D:V.65, D:G.96, D:K.165, D:I.194
- Water bridges: D:A.22, D:F.41, D:F.41, D:F.41, D:D.64, D:I.95, D:Y.158, D:T.196, D:T.196, D:L.197
- pi-Stacking: D:F.41
- 8 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.3: 6 residues within 4Å:- Chain A: D.42, R.43, L.44, R.45, E.62, H.70
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:D.42, A:L.44, A:R.45
- Water bridges: A:L.46
- Salt bridges: A:R.45, A:E.62, A:E.62
EPE.4: 10 residues within 4Å:- Chain A: S.19, H.24, I.194, R.195, T.196, M.232, K.233, D.234, A.235, T.236
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.195, A:K.233, A:A.235
- Salt bridges: A:H.24
EPE.13: 6 residues within 4Å:- Chain B: D.42, R.43, L.44, R.45, E.62, H.70
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:D.42, B:L.44, B:R.45
- Water bridges: B:L.46
- Salt bridges: B:R.45, B:E.62, B:E.62
EPE.14: 10 residues within 4Å:- Chain B: S.19, H.24, I.194, R.195, T.196, M.232, K.233, D.234, A.235, T.236
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.195, B:K.233, B:A.235
- Salt bridges: B:H.24
EPE.23: 6 residues within 4Å:- Chain C: D.42, R.43, L.44, R.45, E.62, H.70
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:D.42, C:L.44, C:R.45
- Water bridges: C:L.46, C:E.62
- Salt bridges: C:R.45, C:E.62, C:E.62
EPE.24: 10 residues within 4Å:- Chain C: S.19, H.24, I.194, R.195, T.196, M.232, K.233, D.234, A.235, T.236
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.195, C:K.233, C:A.235
- Salt bridges: C:H.24
EPE.33: 6 residues within 4Å:- Chain D: D.42, R.43, L.44, R.45, E.62, H.70
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:D.42, D:L.44, D:R.45
- Water bridges: D:L.46, D:E.62
- Salt bridges: D:R.45, D:E.62, D:E.62
EPE.34: 10 residues within 4Å:- Chain D: S.19, H.24, I.194, R.195, T.196, M.232, K.233, D.234, A.235, T.236
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:R.195, D:K.233, D:A.235
- Salt bridges: D:H.24
- 16 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.5: 4 residues within 4Å:- Chain A: I.228, G.229, W.230, N.231
Ligand excluded by PLIPDMS.6: 6 residues within 4Å:- Chain A: I.228
- Chain D: G.141, G.142, G.183, R.185, P.251
Ligand excluded by PLIPDMS.7: 4 residues within 4Å:- Chain A: K.132, P.136, Y.182
- Chain C: F.109
Ligand excluded by PLIPDMS.8: 4 residues within 4Å:- Chain A: E.68, Y.125, K.132
- Chain C: D.110
Ligand excluded by PLIPDMS.15: 4 residues within 4Å:- Chain B: I.228, G.229, W.230, N.231
Ligand excluded by PLIPDMS.16: 6 residues within 4Å:- Chain B: I.228
- Chain C: G.141, G.142, G.183, R.185, P.251
Ligand excluded by PLIPDMS.17: 4 residues within 4Å:- Chain B: K.132, P.136, Y.182
- Chain D: F.109
Ligand excluded by PLIPDMS.18: 4 residues within 4Å:- Chain B: E.68, Y.125, K.132
- Chain D: D.110
Ligand excluded by PLIPDMS.25: 4 residues within 4Å:- Chain C: I.228, G.229, W.230, N.231
Ligand excluded by PLIPDMS.26: 6 residues within 4Å:- Chain B: G.141, G.142, G.183, R.185, P.251
- Chain C: I.228
Ligand excluded by PLIPDMS.27: 4 residues within 4Å:- Chain A: F.109
- Chain C: K.132, P.136, Y.182
Ligand excluded by PLIPDMS.28: 4 residues within 4Å:- Chain A: D.110
- Chain C: E.68, Y.125, K.132
Ligand excluded by PLIPDMS.35: 4 residues within 4Å:- Chain D: I.228, G.229, W.230, N.231
Ligand excluded by PLIPDMS.36: 6 residues within 4Å:- Chain A: G.141, G.142, G.183, R.185, P.251
- Chain D: I.228
Ligand excluded by PLIPDMS.37: 4 residues within 4Å:- Chain B: F.109
- Chain D: K.132, P.136, Y.182
Ligand excluded by PLIPDMS.38: 4 residues within 4Å:- Chain B: D.110
- Chain D: E.68, Y.125, K.132
Ligand excluded by PLIP- 8 x NA: SODIUM ION(Non-functional Binders)
NA.9: 3 residues within 4Å:- Chain A: D.223, Q.224, A.226
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.224
NA.10: 3 residues within 4Å:- Chain A: G.141, R.185, D.248
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.8, A:G.141, A:R.185, A:D.248
NA.19: 3 residues within 4Å:- Chain B: D.223, Q.224, A.226
1 PLIP interactions:1 interactions with chain B- Water bridges: B:Q.224
NA.20: 3 residues within 4Å:- Chain B: G.141, R.185, D.248
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:K.8, B:K.8, B:R.185, B:D.248
NA.29: 3 residues within 4Å:- Chain C: D.223, Q.224, A.226
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.223
NA.30: 3 residues within 4Å:- Chain C: G.141, R.185, D.248
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:K.8, C:R.185, C:D.248
NA.39: 3 residues within 4Å:- Chain D: D.223, Q.224, A.226
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Q.224
NA.40: 3 residues within 4Å:- Chain D: G.141, R.185, D.248
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:K.8, D:G.141, D:R.185
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chollet, A. et al., Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach. J.Struct.Biol. (2015)
- Release Date
- 2015-04-29
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x ZID: ISONICOTINIC-ACETYL-NICOTINAMIDE-ADENINE DINUCLEOTIDE(Covalent)
- 8 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 16 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 8 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chollet, A. et al., Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach. J.Struct.Biol. (2015)
- Release Date
- 2015-04-29
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A